FDA Approved (Rx — IV obstetric)Nasal / SubQ · Neurohormonal

Oxytocin

OT — The Bonding Hormone / Trust Peptide

Half-life
~3-5 min (plasma); ~20 min (CNS)
Route
Intranasal or SubQ
Typical dose
20–40 IU intranasal
Reconstitutable
No — pre-mixed

What is Oxytocin?

Oxytocin is a 9-amino acid neuropeptide produced in the hypothalamus and released from the posterior pituitary. While FDA-approved only for obstetric use (labor induction, postpartum hemorrhage), intranasal oxytocin has been extensively studied for social bonding, anxiety reduction, trust enhancement, autism spectrum disorder, and PTSD — giving it broad interest in the biohacking community.

Oxytocin acts on oxytocin receptors in the brain (amygdala, nucleus accumbens, hippocampus) to reduce fear responses, enhance social reward, promote trust, and reduce cortisol. Intranasal delivery bypasses the blood-brain barrier through the olfactory route, producing CNS effects that IV or subcutaneous routes do not achieve as reliably. Its peripheral effects include uterine contraction, milk letdown, and peripheral anti-inflammatory signaling.

Research Evidence

GoldObstetric Use

Well-established FDA-approved obstetric applications (labor induction, postpartum hemorrhage). Decades of clinical data.

SilverSocial Cognition & Trust

Multiple double-blind RCTs demonstrate intranasal oxytocin improves social recognition, increases trust, reduces amygdala fear response, and enhances emotional face processing in healthy subjects.

SilverAutism & PTSD

Clinical trials show mixed but promising results for social symptom improvement in autism spectrum disorder and anxiety/fear processing in PTSD.

Evidence grades: Gold = RCT human data · Silver = consistent animal/human data · Bronze = limited or preliminary

Dosing Protocols

Intranasal dose
20–40 IU per nostril
Standard research dose is 24 IU total (2 sprays per nostril of standard 10 IU/spray formulation). Effects onset in 30-60 minutes and last 1-2 hours.
Timing
45–60 min before social context
Used acutely before social situations. Not for chronic daily use — oxytocin receptor downregulation with excessive use.
Source
Compounded nasal spray
Available through compounding pharmacies with prescription. Commercial Syntocinon nasal spray no longer available in US.

Reconstitution Guide

This compound does not require reconstitution — it is available as a pre-mixed injectable or oral formulation.

Frequently Asked Questions

Does intranasal oxytocin actually reach the brain?

Yes, through olfactory nerve pathway bypassing the blood-brain barrier. This is well-established in pharmacokinetic research. However, the brain vs peripheral contribution to behavioral effects is still debated — some effects may be partially mediated by peripheral oxytocin receptors. The behavioral effects of intranasal oxytocin on social cognition and trust are consistently reproducible across dozens of RCTs.

Can oxytocin be used for anxiety?

Oxytocin reduces amygdala reactivity to fear stimuli in controlled studies, which theoretically supports anxiety reduction. However, effects are context-dependent — oxytocin enhances in-group bonding and trust but can increase out-group anxiety and suspicion in some studies. It is not a straightforward anxiolytic and is not recommended as a substitute for established anxiety treatments.

References

  1. [1]Kosfeld M, Heinrichs M, Zak PJ, Fischbacher U, Fehr E. Oxytocin increases trust in humans. Nature. 2005;435(7042):673-676.
  2. [2]Guastella AJ, Mitchell PB, Mathews F. Oxytocin enhances the encoding of positive social memories in humans. Biol Psychiatry. 2008;64(3):256-258.
Disclaimer: This profile is for informational and research purposes only. Not medical advice. Always consult a licensed healthcare provider before using any compound.

This profile was prepared using AI-assisted research synthesis. Citations are provided where applicable — verify with primary sources before clinical application.

Share this article